Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis.
about
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusCurrent perspectives on the immunopathogenesis of systemic sclerosisOptical coherence tomography (OCT) of collagen in normal skin and skin fibrosisRecent advances in the genetics of systemic sclerosis: toward biological and clinical significanceIdentification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategyCapillary regeneration in scleroderma: stem cell therapy reverses phenotype?Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.The transcriptional cofactor nab2 is induced by tgf-Beta and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma.Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials?A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate.Iloprost modulates the immune response in systemic sclerosis.Systemic sclerosis-associated pulmonary arterial hypertensionSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesEgr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis.Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.Human collagen Krox up-regulates type I collagen expression in normal and scleroderma fibroblasts through interaction with Sp1 and Sp3 transcription factors.Lung involvement in systemic sclerosis.The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.An official American Thoracic Society Statement: pulmonary hypertension phenotypesPulmonary arterial hypertension associated with systemic sclerosis.Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosisBilateral mandibular condylysis from systemic sclerosis: case report of surgical correction with bilateral total temporomandibular joint replacementVascular involvement in systemic sclerosis (scleroderma).Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis.Scleroderma-like skin changes not involving the hand in a prepubertal male with type I diabetes mellitus: A case report.Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease.Avian models with spontaneous autoimmune diseases.Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-upThe Application of Fluorescence Optical Imaging in Systemic SclerosisPulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management.Pulmonary arterial hypertension in connective tissue diseases.Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study.Acute myocardial infarction in systemic sclerosis patients: a case series.Imaging features of musculoskeletal involvement in systemic sclerosis.Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma.How does endothelial cell injury start? The role of endothelin in systemic sclerosis.
P2860
Q24630434-7C5D9B71-1C32-4BCA-9B95-B1CB82F079B9Q26741264-821DAAC2-14C3-4816-975F-A97297385E94Q26823616-AAEA6927-0562-4EB5-A6A1-D052D3C91E30Q28088499-52A607FE-71E0-4465-A106-97CF75B3C637Q29417020-2B3E7FCC-B9E8-48E2-A127-74931B4821FDQ33314922-3CFA0742-565E-4C6E-BA54-8590A73029F0Q33320557-E1C4CB51-A3A3-448B-B598-05CBD6EAC47CQ33357303-9A09774A-529C-41A4-93AA-1AA03D482DCFQ33514874-D6F1708C-8F9E-45C4-A48D-2D0F8FF8D45FQ33536943-D49B4E04-B6BE-4A5F-9A45-404673D2FB29Q33551475-EB5D1644-7CB7-45C0-870D-5D8830478DC4Q33772202-7A38208A-796E-4D43-8C1E-0437F77137B6Q33950086-F730CEDD-70A6-4E1C-AC71-FE722828FFA7Q33965825-25A9940E-F790-4600-934C-6476A6A33107Q34023076-31E6852D-E173-48C6-91BE-CC0CE8BBCAD9Q34046875-940C78BB-C5BB-4369-BB85-32D16D2FA20AQ34378873-40AA87FB-E72B-44E5-81A5-486A751C0791Q34663211-69A82C66-2D1F-43D3-A246-FC5CD35D10FDQ34732817-5EA8261A-0128-4A65-8C4B-BCF2F5CFA3B2Q34839261-BBB7DE25-01B3-4D9F-AA85-7649E6EC394BQ34919733-3077363E-AB9F-4B53-9FD1-DA66341C8383Q35002423-956DAF0F-3BB1-4317-801E-3F9B07686C9DQ35158836-E58711F5-487D-49C3-803E-54E68FFD3B5AQ35526107-CAE20658-0153-43FF-9D00-BE003D18A631Q35557424-A5423E90-BCCF-4227-8113-1C246DB58495Q35630007-7DF6CA88-D167-481B-9320-D0D89316DE48Q35667404-8C69A738-1644-4065-9CF0-B0DC0D8849C7Q35755610-C6316913-1933-4D04-9CB5-FDBDCFA59694Q35770782-BE65AC64-B6B3-47E8-995C-E4D8C6278D9EQ35799365-4834C878-EB39-4E55-9A67-1A872340748EQ36012302-281F0E18-C32F-4DD8-B449-CA99E34B5C14Q36013149-CD91D76C-20D9-459E-B86C-C43938C0F949Q36013674-12665107-0A50-4821-B410-BF9C281956C7Q36075852-3EECD615-1623-47F2-97D8-62923C2916D1Q36376858-91397511-3AE2-4083-956A-95E08A789230Q36415410-5574BBF5-79B0-4F19-89B8-38E29EFDCF2AQ36614937-DDA13E25-88B9-4240-9A0C-931C6019F6B9Q36761364-0FDB25B9-578B-4308-A046-2AF09128DCE4Q36891532-26FAFAB5-7EC2-462E-8FD3-09F3E0FA15CFQ36927745-19C9F3E2-AA2E-4ACD-B236-450B22A7CE18
P2860
Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Following the molecular pathwa ...... genesis of systemic sclerosis.
@ast
Following the molecular pathwa ...... genesis of systemic sclerosis.
@en
Following the molecular pathwa ...... genesis of systemic sclerosis.
@nl
type
label
Following the molecular pathwa ...... genesis of systemic sclerosis.
@ast
Following the molecular pathwa ...... genesis of systemic sclerosis.
@en
Following the molecular pathwa ...... genesis of systemic sclerosis.
@nl
prefLabel
Following the molecular pathwa ...... genesis of systemic sclerosis.
@ast
Following the molecular pathwa ...... genesis of systemic sclerosis.
@en
Following the molecular pathwa ...... genesis of systemic sclerosis.
@nl
P1476
Following the molecular pathwa ...... genesis of systemic sclerosis.
@en
P2093
Chris T Derk
Sergio A Jimenez
P356
10.7326/0003-4819-140-2-200401200-00013
P407
P577
2004-01-01T00:00:00Z